Sigma receptors and mitochondria-associated ER membranes are converging therapeutic targets for Alzheimer's disease.
Saved in:
| Title: | Sigma receptors and mitochondria-associated ER membranes are converging therapeutic targets for Alzheimer's disease. |
|---|---|
| Authors: | Lotlikar MS; Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Henry and Allison McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States., Zellmer JC; Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Henry and Allison McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States., Bhattacharyya R; Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Henry and Allison McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States. |
| Source: | Frontiers in neuroscience [Front Neurosci] 2025 Dec 19; Vol. 19, pp. 1733659. Date of Electronic Publication: 2025 Dec 19 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101478481 Publication Model: eCollection Cited Medium: Print ISSN: 1662-4548 (Print) Linking ISSN: 1662453X NLM ISO Abbreviation: Front Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
